Skip to content
Screener

Astrana Health ASTH Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$965.1MBeat by $15.9M
EPS$0.74Beat by $0.45
Revenue estimate$949.2M
EPS estimate$0.29

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$1.0B
EPS estimate$0.42

Financials

Q1 2026

Income statement

See full
Revenue$965.1M+55.6%
Gross profit$105.7M+48.2%
Operating income$28.5M+38.6%
Net income$14.4M+116%
EPS (diluted)$0.29+107%

Balance sheet

See full
Cash & equivalents$478.4M+85.0%
Total debt$1.1B+136%
Total equity$800.3M+7.4%
Total assets$2.4B+77.2%

Cash flow

See full
Operating cash flow$68.1M+309%
CapEx$4.0M+30.3%
Free cash flow$64.1M+372%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$1.36B-3.0%
Enterprise value$1.95B+22.0%
P/E45.1×—
P/S0.4×-0.2×

Profitability

See full
Gross margin10.7%-1.3pp
Operating margin2.5%-1.1pp
Net margin0.9%—
FCF margin4.6%—

Returns & leverage

See full
Return on equity3.9%—
Debt / equity1.3×+0.7×
Current ratio1.3×-0.4×

Segments

By product

See full
Health Care Patient Service$37.8M+154%
Management Service$15.7M+579%
Health Care Other$12.5M-13.8%

FAQ

When did Astrana Health report Q1 2026 earnings?
Astrana Health (ASTH) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Astrana Health's Q1 2026 revenue and EPS?
Astrana Health reported revenue of $965.1M and eps of $0.74 for Q1 2026.
Did Astrana Health beat estimates in Q1 2026?
Revenue beat the consensus estimate of $949.2M by $15.9M. EPS beat the consensus estimate of $0.29 by $0.45.
How did Astrana Health's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 55.6% from $620.4M a year earlier and eps grew 428.6% from $0.14.
Where can I find Astrana Health's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-057134) and the 10-Q periodic report (0001193125-26-213157) directly on SEC EDGAR. The filing index links above go to sec.gov.